Skip to main content
TipRanks
Go Ultimate75% OFF

Welgene Biotech Co., Ltd. (6661) Cash flow

Welgene Biotech Co., Ltd. Cash Flow

TW:6661's free cash flow for Q2 2026 was NT$-58.44M. For the 2026 fiscal year, TW:6661's free cash flow was decreased by NT$-66.08M and operating cash flow was NT$7.64M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 35.27MNT$ 56.08MNT$ -366.00KNT$ 51.43MNT$ 11.25M
NT$ -35.74MNT$ -45.19MNT$ 6.00MNT$ -67.99MNT$ -10.34M
NT$ 51.31MNT$ -25.52MNT$ 23.91MNT$ -24.61MNT$ 38.52M
NT$ 226.03MNT$ 173.50MNT$ 188.13MNT$ 158.59MNT$ 199.77M
NT$ -6.08MNT$ 51.27MNT$ -28.10MNT$ 24.57MNT$ 6.87M

Currency in TWD

Welgene Biotech Co., Ltd. Cash Flow

-100M-50M050M100M201720182019202020212022202320242025OperatingInvestingFinancing